nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP2C8—Vismodegib—skin cancer	0.126	0.195	CbGbCtD
Zopiclone—CYP2E1—Dacarbazine—skin cancer	0.102	0.158	CbGbCtD
Zopiclone—CYP2C9—Vismodegib—skin cancer	0.0881	0.136	CbGbCtD
Zopiclone—CYP3A4—Imiquimod—skin cancer	0.0739	0.114	CbGbCtD
Zopiclone—CYP3A4—Temozolomide—skin cancer	0.0739	0.114	CbGbCtD
Zopiclone—CYP3A4—Vismodegib—skin cancer	0.0512	0.0793	CbGbCtD
Zopiclone—CYP2C8—Fluorouracil—skin cancer	0.0449	0.0694	CbGbCtD
Zopiclone—CYP3A4—Vemurafenib—skin cancer	0.0405	0.0626	CbGbCtD
Zopiclone—CYP2C9—Fluorouracil—skin cancer	0.0313	0.0484	CbGbCtD
Zopiclone—CYP3A4—Docetaxel—skin cancer	0.0139	0.0215	CbGbCtD
Zopiclone—TSPO—hindlimb—skin cancer	0.00472	0.104	CbGeAlD
Zopiclone—TSPO—appendage—skin cancer	0.00405	0.0895	CbGeAlD
Zopiclone—TSPO—hair follicle—skin cancer	0.0024	0.0531	CbGeAlD
Zopiclone—GABRA3—neck—skin cancer	0.00234	0.0517	CbGeAlD
Zopiclone—TSPO—blood vessel—skin cancer	0.00225	0.0498	CbGeAlD
Zopiclone—TSPO—nipple—skin cancer	0.00163	0.036	CbGeAlD
Zopiclone—TSPO—neck—skin cancer	0.00161	0.0356	CbGeAlD
Zopiclone—GABRG3—head—skin cancer	0.00138	0.0305	CbGeAlD
Zopiclone—PTGS1—endothelium—skin cancer	0.00136	0.0301	CbGeAlD
Zopiclone—PTGS1—blood vessel—skin cancer	0.00125	0.0277	CbGeAlD
Zopiclone—TSPO—connective tissue—skin cancer	0.00116	0.0255	CbGeAlD
Zopiclone—TSPO—epithelium—skin cancer	0.0011	0.0242	CbGeAlD
Zopiclone—GABRA5—head—skin cancer	0.00106	0.0234	CbGeAlD
Zopiclone—GABRB3—connective tissue—skin cancer	0.00105	0.0232	CbGeAlD
Zopiclone—TSPO—skin of body—skin cancer	0.00104	0.0231	CbGeAlD
Zopiclone—GABRA3—head—skin cancer	0.000988	0.0218	CbGeAlD
Zopiclone—TSPO—mammalian vulva—skin cancer	0.000952	0.021	CbGeAlD
Zopiclone—PTGS1—nipple—skin cancer	0.000907	0.02	CbGeAlD
Zopiclone—TSPO—lymphoid tissue—skin cancer	0.000845	0.0187	CbGeAlD
Zopiclone—TSPO—female reproductive system—skin cancer	0.000815	0.018	CbGeAlD
Zopiclone—GABRG2—head—skin cancer	0.000805	0.0178	CbGeAlD
Zopiclone—GABRB2—head—skin cancer	0.000805	0.0178	CbGeAlD
Zopiclone—GABRB3—female reproductive system—skin cancer	0.00074	0.0164	CbGeAlD
Zopiclone—GABRA2—head—skin cancer	0.000736	0.0163	CbGeAlD
Zopiclone—GABRA1—head—skin cancer	0.000711	0.0157	CbGeAlD
Zopiclone—TSPO—head—skin cancer	0.000681	0.015	CbGeAlD
Zopiclone—PTGS1—connective tissue—skin cancer	0.000643	0.0142	CbGeAlD
Zopiclone—GABRB3—head—skin cancer	0.000618	0.0137	CbGeAlD
Zopiclone—PTGS1—epithelium—skin cancer	0.000611	0.0135	CbGeAlD
Zopiclone—PTGS1—skin of body—skin cancer	0.000581	0.0128	CbGeAlD
Zopiclone—CYP2C8—female reproductive system—skin cancer	0.000559	0.0124	CbGeAlD
Zopiclone—Swelling—Docetaxel—skin cancer	0.000536	0.00174	CcSEcCtD
Zopiclone—Stomatitis—Temozolomide—skin cancer	0.000534	0.00173	CcSEcCtD
Zopiclone—Urinary tract infection—Temozolomide—skin cancer	0.000533	0.00173	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000532	0.00172	CcSEcCtD
Zopiclone—PTGS1—mammalian vulva—skin cancer	0.00053	0.0117	CbGeAlD
Zopiclone—Insomnia—Imiquimod—skin cancer	0.000528	0.00171	CcSEcCtD
Zopiclone—Paraesthesia—Imiquimod—skin cancer	0.000524	0.0017	CcSEcCtD
Zopiclone—Chills—Bleomycin—skin cancer	0.000524	0.0017	CcSEcCtD
Zopiclone—Dyspnoea—Imiquimod—skin cancer	0.00052	0.00169	CcSEcCtD
Zopiclone—Somnolence—Imiquimod—skin cancer	0.000519	0.00168	CcSEcCtD
Zopiclone—Photosensitivity reaction—Fluorouracil—skin cancer	0.000517	0.00168	CcSEcCtD
Zopiclone—Alopecia—Bleomycin—skin cancer	0.000516	0.00167	CcSEcCtD
Zopiclone—GABRA2—lymph node—skin cancer	0.000515	0.0114	CbGeAlD
Zopiclone—Erythema multiforme—Dactinomycin—skin cancer	0.000515	0.00167	CcSEcCtD
Zopiclone—Dyspepsia—Imiquimod—skin cancer	0.000514	0.00167	CcSEcCtD
Zopiclone—Decreased appetite—Imiquimod—skin cancer	0.000507	0.00165	CcSEcCtD
Zopiclone—Hypersensitivity—Vemurafenib—skin cancer	0.000504	0.00164	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Imiquimod—skin cancer	0.000504	0.00163	CcSEcCtD
Zopiclone—Fatigue—Imiquimod—skin cancer	0.000503	0.00163	CcSEcCtD
Zopiclone—Pain—Imiquimod—skin cancer	0.000499	0.00162	CcSEcCtD
Zopiclone—CYP2C9—female reproductive system—skin cancer	0.000497	0.011	CbGeAlD
Zopiclone—Neuropathy peripheral—Fluorouracil—skin cancer	0.000495	0.00161	CcSEcCtD
Zopiclone—Dermatitis bullous—Docetaxel—skin cancer	0.000495	0.00161	CcSEcCtD
Zopiclone—Stomatitis—Fluorouracil—skin cancer	0.000492	0.0016	CcSEcCtD
Zopiclone—Hepatitis—Temozolomide—skin cancer	0.000492	0.0016	CcSEcCtD
Zopiclone—Urinary tract infection—Fluorouracil—skin cancer	0.000491	0.00159	CcSEcCtD
Zopiclone—Conjunctivitis—Fluorouracil—skin cancer	0.000491	0.00159	CcSEcCtD
Zopiclone—Asthenia—Vemurafenib—skin cancer	0.000491	0.00159	CcSEcCtD
Zopiclone—Hallucination—Temozolomide—skin cancer	0.00049	0.00159	CcSEcCtD
Zopiclone—Hypoaesthesia—Temozolomide—skin cancer	0.00049	0.00159	CcSEcCtD
Zopiclone—Pharyngitis—Temozolomide—skin cancer	0.000489	0.00158	CcSEcCtD
Zopiclone—CYP2E1—lymphoid tissue—skin cancer	0.000488	0.0108	CbGeAlD
Zopiclone—Chills—Dactinomycin—skin cancer	0.000488	0.00158	CcSEcCtD
Zopiclone—Oedema peripheral—Temozolomide—skin cancer	0.000485	0.00157	CcSEcCtD
Zopiclone—Pruritus—Vemurafenib—skin cancer	0.000484	0.00157	CcSEcCtD
Zopiclone—Alopecia—Dactinomycin—skin cancer	0.000481	0.00156	CcSEcCtD
Zopiclone—Feeling abnormal—Imiquimod—skin cancer	0.000481	0.00156	CcSEcCtD
Zopiclone—Gastrointestinal pain—Imiquimod—skin cancer	0.000477	0.00155	CcSEcCtD
Zopiclone—TSPO—lymph node—skin cancer	0.000477	0.0105	CbGeAlD
Zopiclone—Epistaxis—Fluorouracil—skin cancer	0.000477	0.00155	CcSEcCtD
Zopiclone—Ill-defined disorder—Bleomycin—skin cancer	0.000471	0.00153	CcSEcCtD
Zopiclone—CYP2E1—female reproductive system—skin cancer	0.000471	0.0104	CbGeAlD
Zopiclone—Anaemia—Bleomycin—skin cancer	0.000469	0.00152	CcSEcCtD
Zopiclone—Diarrhoea—Vemurafenib—skin cancer	0.000468	0.00152	CcSEcCtD
Zopiclone—Migraine—Docetaxel—skin cancer	0.000466	0.00151	CcSEcCtD
Zopiclone—Erythema multiforme—Temozolomide—skin cancer	0.000465	0.00151	CcSEcCtD
Zopiclone—Urticaria—Imiquimod—skin cancer	0.000464	0.0015	CcSEcCtD
Zopiclone—Body temperature increased—Imiquimod—skin cancer	0.000461	0.0015	CcSEcCtD
Zopiclone—Abdominal pain—Imiquimod—skin cancer	0.000461	0.0015	CcSEcCtD
Zopiclone—Tinnitus—Temozolomide—skin cancer	0.000459	0.00149	CcSEcCtD
Zopiclone—Malaise—Bleomycin—skin cancer	0.000458	0.00149	CcSEcCtD
Zopiclone—Rhinitis—Fluorouracil—skin cancer	0.000455	0.00147	CcSEcCtD
Zopiclone—PTGS1—female reproductive system—skin cancer	0.000454	0.01	CbGeAlD
Zopiclone—Dizziness—Vemurafenib—skin cancer	0.000452	0.00147	CcSEcCtD
Zopiclone—Hypoaesthesia—Fluorouracil—skin cancer	0.000451	0.00146	CcSEcCtD
Zopiclone—Pharyngitis—Fluorouracil—skin cancer	0.00045	0.00146	CcSEcCtD
Zopiclone—Ataxia—Docetaxel—skin cancer	0.000445	0.00144	CcSEcCtD
Zopiclone—Chills—Temozolomide—skin cancer	0.000442	0.00143	CcSEcCtD
Zopiclone—Dehydration—Docetaxel—skin cancer	0.00044	0.00143	CcSEcCtD
Zopiclone—Ill-defined disorder—Dactinomycin—skin cancer	0.00044	0.00143	CcSEcCtD
Zopiclone—Anaemia—Dactinomycin—skin cancer	0.000438	0.00142	CcSEcCtD
Zopiclone—Vomiting—Vemurafenib—skin cancer	0.000435	0.00141	CcSEcCtD
Zopiclone—Alopecia—Temozolomide—skin cancer	0.000435	0.00141	CcSEcCtD
Zopiclone—Dry skin—Docetaxel—skin cancer	0.000434	0.00141	CcSEcCtD
Zopiclone—Chest pain—Bleomycin—skin cancer	0.000432	0.0014	CcSEcCtD
Zopiclone—Myalgia—Bleomycin—skin cancer	0.000432	0.0014	CcSEcCtD
Zopiclone—Rash—Vemurafenib—skin cancer	0.000431	0.0014	CcSEcCtD
Zopiclone—Dermatitis—Vemurafenib—skin cancer	0.000431	0.0014	CcSEcCtD
Zopiclone—Hypersensitivity—Imiquimod—skin cancer	0.00043	0.00139	CcSEcCtD
Zopiclone—Headache—Vemurafenib—skin cancer	0.000429	0.00139	CcSEcCtD
Zopiclone—Discomfort—Bleomycin—skin cancer	0.000427	0.00139	CcSEcCtD
Zopiclone—Malaise—Dactinomycin—skin cancer	0.000427	0.00139	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000426	0.00138	CcSEcCtD
Zopiclone—Cramp muscle—Docetaxel—skin cancer	0.000426	0.00138	CcSEcCtD
Zopiclone—Dysgeusia—Temozolomide—skin cancer	0.00042	0.00136	CcSEcCtD
Zopiclone—Asthenia—Imiquimod—skin cancer	0.000419	0.00136	CcSEcCtD
Zopiclone—Confusional state—Bleomycin—skin cancer	0.000418	0.00136	CcSEcCtD
Zopiclone—Anaphylactic shock—Bleomycin—skin cancer	0.000415	0.00134	CcSEcCtD
Zopiclone—Back pain—Temozolomide—skin cancer	0.000414	0.00134	CcSEcCtD
Zopiclone—Pruritus—Imiquimod—skin cancer	0.000413	0.00134	CcSEcCtD
Zopiclone—Infection—Bleomycin—skin cancer	0.000412	0.00134	CcSEcCtD
Zopiclone—Dysphagia—Docetaxel—skin cancer	0.000409	0.00133	CcSEcCtD
Zopiclone—Nausea—Vemurafenib—skin cancer	0.000406	0.00132	CcSEcCtD
Zopiclone—Vision blurred—Temozolomide—skin cancer	0.000404	0.00131	CcSEcCtD
Zopiclone—Myalgia—Dactinomycin—skin cancer	0.000403	0.00131	CcSEcCtD
Zopiclone—Tremor—Temozolomide—skin cancer	0.000401	0.0013	CcSEcCtD
Zopiclone—Alopecia—Fluorouracil—skin cancer	0.000401	0.0013	CcSEcCtD
Zopiclone—Diarrhoea—Imiquimod—skin cancer	0.000399	0.0013	CcSEcCtD
Zopiclone—Discomfort—Dactinomycin—skin cancer	0.000398	0.00129	CcSEcCtD
Zopiclone—Ill-defined disorder—Temozolomide—skin cancer	0.000398	0.00129	CcSEcCtD
Zopiclone—Anaemia—Temozolomide—skin cancer	0.000396	0.00128	CcSEcCtD
Zopiclone—Anorexia—Bleomycin—skin cancer	0.000395	0.00128	CcSEcCtD
Zopiclone—Agitation—Temozolomide—skin cancer	0.000394	0.00128	CcSEcCtD
Zopiclone—CYP2E1—head—skin cancer	0.000393	0.00869	CbGeAlD
Zopiclone—Angioedema—Temozolomide—skin cancer	0.000392	0.00127	CcSEcCtD
Zopiclone—Malaise—Temozolomide—skin cancer	0.000386	0.00125	CcSEcCtD
Zopiclone—Dizziness—Imiquimod—skin cancer	0.000386	0.00125	CcSEcCtD
Zopiclone—Vertigo—Temozolomide—skin cancer	0.000385	0.00125	CcSEcCtD
Zopiclone—Infection—Dactinomycin—skin cancer	0.000384	0.00125	CcSEcCtD
Zopiclone—PTGS1—head—skin cancer	0.000379	0.00837	CbGeAlD
Zopiclone—CYP3A4—female reproductive system—skin cancer	0.000379	0.00837	CbGeAlD
Zopiclone—Palpitations—Temozolomide—skin cancer	0.000379	0.00123	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000378	0.00123	CcSEcCtD
Zopiclone—Paraesthesia—Bleomycin—skin cancer	0.000372	0.00121	CcSEcCtD
Zopiclone—Weight increased—Docetaxel—skin cancer	0.000372	0.00121	CcSEcCtD
Zopiclone—Vision blurred—Fluorouracil—skin cancer	0.000372	0.00121	CcSEcCtD
Zopiclone—Convulsion—Temozolomide—skin cancer	0.000371	0.0012	CcSEcCtD
Zopiclone—Vomiting—Imiquimod—skin cancer	0.000371	0.0012	CcSEcCtD
Zopiclone—Weight decreased—Docetaxel—skin cancer	0.00037	0.0012	CcSEcCtD
Zopiclone—Hypertension—Temozolomide—skin cancer	0.00037	0.0012	CcSEcCtD
Zopiclone—Dyspnoea—Bleomycin—skin cancer	0.00037	0.0012	CcSEcCtD
Zopiclone—Anorexia—Dactinomycin—skin cancer	0.000369	0.0012	CcSEcCtD
Zopiclone—Rash—Imiquimod—skin cancer	0.000368	0.00119	CcSEcCtD
Zopiclone—Dermatitis—Imiquimod—skin cancer	0.000368	0.00119	CcSEcCtD
Zopiclone—Headache—Imiquimod—skin cancer	0.000366	0.00119	CcSEcCtD
Zopiclone—Anaemia—Fluorouracil—skin cancer	0.000365	0.00118	CcSEcCtD
Zopiclone—Myalgia—Temozolomide—skin cancer	0.000365	0.00118	CcSEcCtD
Zopiclone—Anxiety—Temozolomide—skin cancer	0.000364	0.00118	CcSEcCtD
Zopiclone—Discomfort—Temozolomide—skin cancer	0.00036	0.00117	CcSEcCtD
Zopiclone—Decreased appetite—Bleomycin—skin cancer	0.00036	0.00117	CcSEcCtD
Zopiclone—Neuropathy peripheral—Docetaxel—skin cancer	0.000357	0.00116	CcSEcCtD
Zopiclone—Dry mouth—Temozolomide—skin cancer	0.000357	0.00116	CcSEcCtD
Zopiclone—Stomatitis—Docetaxel—skin cancer	0.000355	0.00115	CcSEcCtD
Zopiclone—Pain—Bleomycin—skin cancer	0.000355	0.00115	CcSEcCtD
Zopiclone—Conjunctivitis—Docetaxel—skin cancer	0.000354	0.00115	CcSEcCtD
Zopiclone—Confusional state—Temozolomide—skin cancer	0.000353	0.00114	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000352	0.00114	CcSEcCtD
Zopiclone—Anaphylactic shock—Temozolomide—skin cancer	0.00035	0.00113	CcSEcCtD
Zopiclone—Infection—Temozolomide—skin cancer	0.000347	0.00113	CcSEcCtD
Zopiclone—Nausea—Imiquimod—skin cancer	0.000347	0.00112	CcSEcCtD
Zopiclone—Epistaxis—Docetaxel—skin cancer	0.000344	0.00112	CcSEcCtD
Zopiclone—Convulsion—Fluorouracil—skin cancer	0.000342	0.00111	CcSEcCtD
Zopiclone—Feeling abnormal—Bleomycin—skin cancer	0.000342	0.00111	CcSEcCtD
Zopiclone—Hyperhidrosis—Temozolomide—skin cancer	0.000338	0.0011	CcSEcCtD
Zopiclone—Chest pain—Fluorouracil—skin cancer	0.000336	0.00109	CcSEcCtD
Zopiclone—Myalgia—Fluorouracil—skin cancer	0.000336	0.00109	CcSEcCtD
Zopiclone—Decreased appetite—Dactinomycin—skin cancer	0.000336	0.00109	CcSEcCtD
Zopiclone—Fatigue—Dactinomycin—skin cancer	0.000333	0.00108	CcSEcCtD
Zopiclone—Anorexia—Temozolomide—skin cancer	0.000333	0.00108	CcSEcCtD
Zopiclone—Discomfort—Fluorouracil—skin cancer	0.000332	0.00108	CcSEcCtD
Zopiclone—Pain—Dactinomycin—skin cancer	0.000331	0.00107	CcSEcCtD
Zopiclone—Urticaria—Bleomycin—skin cancer	0.000329	0.00107	CcSEcCtD
Zopiclone—Rhinitis—Docetaxel—skin cancer	0.000328	0.00106	CcSEcCtD
Zopiclone—Body temperature increased—Bleomycin—skin cancer	0.000328	0.00106	CcSEcCtD
Zopiclone—Hepatitis—Docetaxel—skin cancer	0.000327	0.00106	CcSEcCtD
Zopiclone—Hypoaesthesia—Docetaxel—skin cancer	0.000326	0.00106	CcSEcCtD
Zopiclone—Confusional state—Fluorouracil—skin cancer	0.000325	0.00105	CcSEcCtD
Zopiclone—Pharyngitis—Docetaxel—skin cancer	0.000325	0.00105	CcSEcCtD
Zopiclone—Oedema peripheral—Docetaxel—skin cancer	0.000322	0.00105	CcSEcCtD
Zopiclone—Anaphylactic shock—Fluorouracil—skin cancer	0.000322	0.00105	CcSEcCtD
Zopiclone—Infection—Fluorouracil—skin cancer	0.00032	0.00104	CcSEcCtD
Zopiclone—Feeling abnormal—Dactinomycin—skin cancer	0.000319	0.00103	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000319	0.00103	CcSEcCtD
Zopiclone—Insomnia—Temozolomide—skin cancer	0.000316	0.00103	CcSEcCtD
Zopiclone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000316	0.00103	CcSEcCtD
Zopiclone—Tachycardia—Fluorouracil—skin cancer	0.000314	0.00102	CcSEcCtD
Zopiclone—Paraesthesia—Temozolomide—skin cancer	0.000314	0.00102	CcSEcCtD
Zopiclone—Dyspnoea—Temozolomide—skin cancer	0.000312	0.00101	CcSEcCtD
Zopiclone—Somnolence—Temozolomide—skin cancer	0.000311	0.00101	CcSEcCtD
Zopiclone—Erythema multiforme—Docetaxel—skin cancer	0.000309	0.001	CcSEcCtD
Zopiclone—Dyspepsia—Temozolomide—skin cancer	0.000308	0.000999	CcSEcCtD
Zopiclone—Anorexia—Fluorouracil—skin cancer	0.000307	0.000996	CcSEcCtD
Zopiclone—Abdominal pain—Dactinomycin—skin cancer	0.000306	0.000991	CcSEcCtD
Zopiclone—Body temperature increased—Dactinomycin—skin cancer	0.000306	0.000991	CcSEcCtD
Zopiclone—Hypersensitivity—Bleomycin—skin cancer	0.000305	0.000991	CcSEcCtD
Zopiclone—Decreased appetite—Temozolomide—skin cancer	0.000304	0.000986	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000302	0.000979	CcSEcCtD
Zopiclone—Fatigue—Temozolomide—skin cancer	0.000301	0.000978	CcSEcCtD
Zopiclone—Pain—Temozolomide—skin cancer	0.000299	0.00097	CcSEcCtD
Zopiclone—Constipation—Temozolomide—skin cancer	0.000299	0.00097	CcSEcCtD
Zopiclone—Asthenia—Bleomycin—skin cancer	0.000297	0.000965	CcSEcCtD
Zopiclone—Chills—Docetaxel—skin cancer	0.000294	0.000953	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000294	0.000952	CcSEcCtD
Zopiclone—Pruritus—Bleomycin—skin cancer	0.000293	0.000951	CcSEcCtD
Zopiclone—Insomnia—Fluorouracil—skin cancer	0.000291	0.000945	CcSEcCtD
Zopiclone—Paraesthesia—Fluorouracil—skin cancer	0.000289	0.000939	CcSEcCtD
Zopiclone—Alopecia—Docetaxel—skin cancer	0.000289	0.000938	CcSEcCtD
Zopiclone—Feeling abnormal—Temozolomide—skin cancer	0.000288	0.000935	CcSEcCtD
Zopiclone—Dyspnoea—Fluorouracil—skin cancer	0.000287	0.000932	CcSEcCtD
Zopiclone—Somnolence—Fluorouracil—skin cancer	0.000286	0.000929	CcSEcCtD
Zopiclone—Gastrointestinal pain—Temozolomide—skin cancer	0.000286	0.000928	CcSEcCtD
Zopiclone—Hypersensitivity—Dactinomycin—skin cancer	0.000285	0.000924	CcSEcCtD
Zopiclone—Dyspepsia—Fluorouracil—skin cancer	0.000284	0.00092	CcSEcCtD
Zopiclone—Decreased appetite—Fluorouracil—skin cancer	0.00028	0.000909	CcSEcCtD
Zopiclone—Dysgeusia—Docetaxel—skin cancer	0.000279	0.000905	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000278	0.000902	CcSEcCtD
Zopiclone—Urticaria—Temozolomide—skin cancer	0.000278	0.000901	CcSEcCtD
Zopiclone—Asthenia—Dactinomycin—skin cancer	0.000277	0.0009	CcSEcCtD
Zopiclone—Body temperature increased—Temozolomide—skin cancer	0.000276	0.000897	CcSEcCtD
Zopiclone—Abdominal pain—Temozolomide—skin cancer	0.000276	0.000897	CcSEcCtD
Zopiclone—Back pain—Docetaxel—skin cancer	0.000276	0.000894	CcSEcCtD
Zopiclone—Pain—Fluorouracil—skin cancer	0.000276	0.000894	CcSEcCtD
Zopiclone—Muscle spasms—Docetaxel—skin cancer	0.000274	0.000889	CcSEcCtD
Zopiclone—Feeling abnormal—Fluorouracil—skin cancer	0.000266	0.000861	CcSEcCtD
Zopiclone—PTGS1—lymph node—skin cancer	0.000265	0.00586	CbGeAlD
Zopiclone—Diarrhoea—Dactinomycin—skin cancer	0.000265	0.000858	CcSEcCtD
Zopiclone—Vomiting—Bleomycin—skin cancer	0.000264	0.000855	CcSEcCtD
Zopiclone—Anaemia—Docetaxel—skin cancer	0.000263	0.000854	CcSEcCtD
Zopiclone—Rash—Bleomycin—skin cancer	0.000261	0.000848	CcSEcCtD
Zopiclone—Dermatitis—Bleomycin—skin cancer	0.000261	0.000847	CcSEcCtD
Zopiclone—Hypersensitivity—Temozolomide—skin cancer	0.000258	0.000836	CcSEcCtD
Zopiclone—Urticaria—Fluorouracil—skin cancer	0.000256	0.00083	CcSEcCtD
Zopiclone—Body temperature increased—Fluorouracil—skin cancer	0.000255	0.000826	CcSEcCtD
Zopiclone—Palpitations—Docetaxel—skin cancer	0.000252	0.000817	CcSEcCtD
Zopiclone—Asthenia—Temozolomide—skin cancer	0.000251	0.000814	CcSEcCtD
Zopiclone—Pruritus—Temozolomide—skin cancer	0.000247	0.000803	CcSEcCtD
Zopiclone—Convulsion—Docetaxel—skin cancer	0.000247	0.000801	CcSEcCtD
Zopiclone—Nausea—Bleomycin—skin cancer	0.000246	0.000799	CcSEcCtD
Zopiclone—Hypertension—Docetaxel—skin cancer	0.000246	0.000798	CcSEcCtD
Zopiclone—Vomiting—Dactinomycin—skin cancer	0.000246	0.000797	CcSEcCtD
Zopiclone—Rash—Dactinomycin—skin cancer	0.000244	0.000791	CcSEcCtD
Zopiclone—Chest pain—Docetaxel—skin cancer	0.000243	0.000787	CcSEcCtD
Zopiclone—Myalgia—Docetaxel—skin cancer	0.000243	0.000787	CcSEcCtD
Zopiclone—Diarrhoea—Temozolomide—skin cancer	0.000239	0.000776	CcSEcCtD
Zopiclone—Hypersensitivity—Fluorouracil—skin cancer	0.000237	0.00077	CcSEcCtD
Zopiclone—Dry mouth—Docetaxel—skin cancer	0.000237	0.00077	CcSEcCtD
Zopiclone—Confusional state—Docetaxel—skin cancer	0.000234	0.000761	CcSEcCtD
Zopiclone—Anaphylactic shock—Docetaxel—skin cancer	0.000233	0.000754	CcSEcCtD
Zopiclone—Dizziness—Temozolomide—skin cancer	0.000231	0.00075	CcSEcCtD
Zopiclone—Infection—Docetaxel—skin cancer	0.000231	0.000749	CcSEcCtD
Zopiclone—Nausea—Dactinomycin—skin cancer	0.00023	0.000745	CcSEcCtD
Zopiclone—Pruritus—Fluorouracil—skin cancer	0.000228	0.000739	CcSEcCtD
Zopiclone—Tachycardia—Docetaxel—skin cancer	0.000227	0.000736	CcSEcCtD
Zopiclone—Vomiting—Temozolomide—skin cancer	0.000222	0.000721	CcSEcCtD
Zopiclone—Anorexia—Docetaxel—skin cancer	0.000222	0.000719	CcSEcCtD
Zopiclone—Rash—Temozolomide—skin cancer	0.00022	0.000715	CcSEcCtD
Zopiclone—Diarrhoea—Fluorouracil—skin cancer	0.00022	0.000715	CcSEcCtD
Zopiclone—Dermatitis—Temozolomide—skin cancer	0.00022	0.000715	CcSEcCtD
Zopiclone—Headache—Temozolomide—skin cancer	0.000219	0.000711	CcSEcCtD
Zopiclone—Dizziness—Fluorouracil—skin cancer	0.000213	0.000691	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000212	0.000687	CcSEcCtD
Zopiclone—Insomnia—Docetaxel—skin cancer	0.00021	0.000682	CcSEcCtD
Zopiclone—Paraesthesia—Docetaxel—skin cancer	0.000209	0.000677	CcSEcCtD
Zopiclone—Nausea—Temozolomide—skin cancer	0.000208	0.000674	CcSEcCtD
Zopiclone—Dyspnoea—Docetaxel—skin cancer	0.000207	0.000673	CcSEcCtD
Zopiclone—Somnolence—Docetaxel—skin cancer	0.000207	0.000671	CcSEcCtD
Zopiclone—Vomiting—Fluorouracil—skin cancer	0.000205	0.000665	CcSEcCtD
Zopiclone—Dyspepsia—Docetaxel—skin cancer	0.000205	0.000664	CcSEcCtD
Zopiclone—Rash—Fluorouracil—skin cancer	0.000203	0.000659	CcSEcCtD
Zopiclone—Dermatitis—Fluorouracil—skin cancer	0.000203	0.000658	CcSEcCtD
Zopiclone—Decreased appetite—Docetaxel—skin cancer	0.000202	0.000656	CcSEcCtD
Zopiclone—Headache—Fluorouracil—skin cancer	0.000202	0.000655	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000201	0.000651	CcSEcCtD
Zopiclone—Fatigue—Docetaxel—skin cancer	0.000201	0.00065	CcSEcCtD
Zopiclone—Pain—Docetaxel—skin cancer	0.000199	0.000645	CcSEcCtD
Zopiclone—Constipation—Docetaxel—skin cancer	0.000199	0.000645	CcSEcCtD
Zopiclone—Feeling abnormal—Docetaxel—skin cancer	0.000192	0.000622	CcSEcCtD
Zopiclone—Nausea—Fluorouracil—skin cancer	0.000191	0.000621	CcSEcCtD
Zopiclone—Gastrointestinal pain—Docetaxel—skin cancer	0.00019	0.000617	CcSEcCtD
Zopiclone—Body temperature increased—Docetaxel—skin cancer	0.000184	0.000596	CcSEcCtD
Zopiclone—Abdominal pain—Docetaxel—skin cancer	0.000184	0.000596	CcSEcCtD
Zopiclone—Hypersensitivity—Docetaxel—skin cancer	0.000171	0.000556	CcSEcCtD
Zopiclone—Asthenia—Docetaxel—skin cancer	0.000167	0.000541	CcSEcCtD
Zopiclone—Pruritus—Docetaxel—skin cancer	0.000165	0.000534	CcSEcCtD
Zopiclone—Diarrhoea—Docetaxel—skin cancer	0.000159	0.000516	CcSEcCtD
Zopiclone—Dizziness—Docetaxel—skin cancer	0.000154	0.000499	CcSEcCtD
Zopiclone—Vomiting—Docetaxel—skin cancer	0.000148	0.00048	CcSEcCtD
Zopiclone—Rash—Docetaxel—skin cancer	0.000147	0.000476	CcSEcCtD
Zopiclone—Dermatitis—Docetaxel—skin cancer	0.000146	0.000475	CcSEcCtD
Zopiclone—Headache—Docetaxel—skin cancer	0.000146	0.000473	CcSEcCtD
Zopiclone—Nausea—Docetaxel—skin cancer	0.000138	0.000448	CcSEcCtD
